Sandler Capital Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-17,033
| Closed | -$5.58M | – | 211 |
|
|
2024
Q4 | $5.58M | Buy |
+17,033
| New | +$5.36M | 0.91% | 70 |
|
|
2024
Q2 | – | Sell |
-14,694
| Closed | -$5.81M | – | 210 |
|
|
2024
Q1 | $5.81M | Sell |
14,694
-30,270
| -67% | -$11.2M | 0.71% | 89 |
|
|
2023
Q4 | $15.8M | Buy |
44,964
+27,210
| +153% | +$9.63M | 2.04% | 26 |
|
|
2023
Q3 | $6.66M | Buy |
17,754
+4,754
| +37% | +$1.84M | 1.13% | 60 |
|
|
2023
Q2 | $4.97M | Sell |
13,000
-1,964
| -13% | -$702K | 0.61% | 73 |
|
|
2023
Q1 | $5.18M | Buy |
+14,964
| New | +$4.37M | 0.85% | 67 |
|
|
2021
Q1 | – | Sell |
-11,477
| Closed | -$3.25M | – | 142 |
|
|
2020
Q4 | $3.25M | Sell |
11,477
-19,100
| -62% | -$5.36M | 0.47% | 65 |
|
|
2020
Q3 | $8.41M | Sell |
30,577
-55,693
| -65% | -$14.7M | 1.3% | 41 |
|
|
2020
Q2 | $19.6M | Buy |
+86,270
| New | +$17M | 3.12% | 18 |
|
|
2017
Q3 | – | Sell |
-70,024
| Closed | -$6.62M | – | 182 |
|
|
2017
Q2 | $6.62M | Sell |
70,024
-65,720
| -48% | -$6.04M | 1.04% | 51 |
|
|
2017
Q1 | $11.1M | Buy |
135,744
+25,844
| +24% | +$2.16M | 1.16% | 35 |
|
|
2016
Q4 | $9.32M | Buy |
109,900
+44,900
| +69% | +$3.53M | 1.15% | 43 |
|
|
2016
Q3 | $4.84M | Buy |
+65,000
| New | +$5.16M | 0.82% | 63 |
|
|
2015
Q3 | – | Sell |
-90,997
| Closed | -$5.29M | – | 224 |
|
|
2015
Q2 | $5.29M | Sell |
90,997
-45,083
| -33% | -$2.52M | 0.65% | 89 |
|
|
2015
Q1 | $8.19M | Sell |
136,080
-25,120
| -16% | -$1.34M | 0.64% | 75 |
|
|
2014
Q4 | $8.58M | Buy |
161,200
+81,200
| +102% | +$4.06M | 0.68% | 76 |
|
|
2014
Q3 | $3.58M | Buy |
+80,000
| New | +$3.4M | 0.27% | 150 |
|
Other funds holding WST
DCP
